Modeling neurofibromatosis type 1 tumors in the mouse for therapeutic intervention
1Center for Developmental Biology, University of Texas Southwestern Medical Center, Dallas, 75390-9133, USA.
Abstract:
Von Recklinghausen's neurofibromatosis is a dominantly inherited cancer syndrome. Its gene encodes neurofibromin, a protein with ras GTPase-activating function (rasGAP) and, therefore, all NF1-associated pathology is thought to originate from selective deregulation of the ras pathway. We have constructed a variety of mouse models for NF1 that permit recapitulation of the most common tumors seen in patients. In addition, these mouse models offer insights into tumor origin and into paracrine interactions. Given the molecular and pathological fidelity of the mouse tumors to the human counterparts, it is hoped that these mouse strains will serve as effective tools for therapeutic discovery.
Insights
Neurofibromatosis type 1 (NF1) is a cancer syndrome. Mouse models were created to study NF1 tumors, providing insights into their origin and potential for therapeutic discovery.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Neurofibromatosis type 1 (NF1) is an inherited cancer syndrome caused by mutations in the NF1 gene.
- The NF1 gene encodes neurofibromin, a protein regulating the ras GTPase-activating pathway (rasGAP).
- NF1-associated pathologies are believed to stem from dysregulation of the ras pathway.
Purpose of the Study:
- To develop and utilize mouse models that accurately replicate human NF1 tumors.
- To investigate the origins of NF1-associated tumors.
- To explore paracrine interactions involved in NF1 tumor development.
Main Methods:
- Construction of diverse mouse models for NF1.
- Characterization of tumors developed in these mouse models.
- Comparative analysis of molecular and pathological features between mouse and human NF1 tumors.
Main Results:
- Successfully generated mouse models recapitulating common NF1 tumors.
- Mouse models provided insights into tumor origins and paracrine signaling.
- Demonstrated high molecular and pathological fidelity between mouse and human NF1 tumors.
Conclusions:
- Developed genetically engineered mouse models for NF1 research.
- These models serve as valuable tools for understanding NF1 tumorigenesis.
- The mouse models are anticipated to facilitate the discovery of new therapeutics for NF1.
